BioNTech, Pfizer secure regulatory approval for COVID-19 vaccine trial in Germany
BioNTech and Pfizer have joined forces to develop BNT162, the vaccine that has potential to prevent the COVID-19…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Apr 20
BioNTech and Pfizer have joined forces to develop BNT162, the vaccine that has potential to prevent the COVID-19…
22 Apr 20
The company has partnered with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics to conduct the…
17 Apr 20
Convalescent plasma is an antibody-based product, developed from blood donated by people who have recovered from the disease…
17 Apr 20
The new data includes interim exploratory results from the real-world TELESCOPE trial, real-world PERISCOPE study and other long…
15 Apr 20
Sanofi and GSK are planning to begin a phase 1 clinical trial in the second half of 2020,…
15 Apr 20
The trial, called CALAVI, evaluates the effect of Calquence on the exaggerated immune response of patients hospitalised with…
14 Apr 20
Bausch Health is collaborating with multiple health authorities to develop VIRAZOLE as a potential treatment for COVID-19
14 Apr 20
Hope Bio’s core technology delivers high-quality, fully characterised, fresh mesenchymal stem cells with immunomodulatory and regenerative capabilities
13 Apr 20
NF1 is a rare and debilitating genetic condition, where 30-50% of patients with NF1 experience PN tumours growing…
09 Apr 20
BRAFTOVI plus cetuximab is an FDA approved regimen indicated for adults with previously treated metastatic CRC with a…